Cincinnati, OH5 Active Studies

Duchenne Muscular Dystrophy Clinical Trials in Cincinnati, OH

Find 5 actively recruiting duchenne muscular dystrophy clinical trials in Cincinnati, OH. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
167
Enrolling

Recruiting Duchenne Muscular Dystrophy Studies in Cincinnati

NCT05693142Recruiting

AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)

RGX-202 is a gene therapy designed to deliver a transgene for a novel microdystrophin that includes functional elements of naturally-occurring dystrophin including the C-Terminal (CT) domain. This is...

Cincinnati, OH65 participantsREGENXBIO Inc.
View Study Details
NCT06503367Recruiting

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

The goal of this observational study is to understand how young children with LAMA2-related dystrophy move and change over time. We will also learn about how this condition impacts other body systems....

Cincinnati, OH44 participantsNationwide Children's Hospital
View Study Details
NCT05412394Recruiting

Once Weekly Infant Corticosteroid Trial for DMD

The hypothesis tested here is that a lower dose of intermittent oral corticosteroids (5mg/kg/week) will be equally effective to the 10mg/kg/week dose....

Cincinnati, OH26 participantsAnne M. Connolly
View Study Details
NCT05996003Recruiting

NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

This is a Phase 2, open-label, multi-center, 2-part study of NS-089/NCNP-02 administered by weekly IV infusion to ambulant boys aged ≥4 to \<15 years with DMD due to mutations amenable to exon 44 skip...

Cincinnati, OH20 participantsNS Pharma, Inc.
View Study Details
NCT06224660Recruiting

Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy

This research study is testing whether an experimental drug, called SRD-001, is safe and helps the weakened heart of patients with Duchenne muscular dystrophy (DMD) regain its ability to effectively p...

Cincinnati, OH12 participantsSardocor Corp.
View Study Details

About Duchenne Muscular Dystrophy Clinical Trials in Cincinnati

Duchenne muscular dystrophy is a severe genetic disorder characterized by progressive muscle degeneration and weakness, primarily affecting boys. It is caused by mutations in the dystrophin gene. Treatment includes corticosteroids, gene therapies, and supportive care to maintain mobility and function.

There are currently 5 duchenne muscular dystrophy clinical trials recruiting participants in Cincinnati, OH. These studies are seeking a combined 167 participants. Research is being sponsored by REGENXBIO Inc., Nationwide Children's Hospital, Anne M. Connolly and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Duchenne Muscular Dystrophy Clinical Trials in Cincinnati — FAQ

Are there duchenne muscular dystrophy clinical trials in Cincinnati?

Yes, there are 5 duchenne muscular dystrophy clinical trials currently recruiting in Cincinnati, OH. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Cincinnati?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cincinnati research site will contact you about next steps.

Are clinical trials in Cincinnati free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cincinnati studies also compensate for your time and travel.

What duchenne muscular dystrophy treatments are being tested?

The 5 active trials in Cincinnati are testing new therapies including novel drugs, biologics, and treatment approaches for duchenne muscular dystrophy.

Data updated July 13, 2026 from ClinicalTrials.gov